{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:02:37Z","timestamp":1788566557739,"version":"build-2803163510"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Age plays a significant role in susceptibility to enterotoxigenic <jats:italic>Escherichia coli<\/jats:italic> (ETEC) infections, yet the distribution of ETEC virulence factors across age groups remains understudied. This study investigated the differential pathogenic profiles ETEC across various age groups, emphasizing the importance of selecting potential ETEC antigens tailored to infection patterns in infants and adults in Bangladesh.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study utilized the icddr,b\u2019s 2% systematic hospital surveillance data of diarrheal patients (<jats:italic>n<\/jats:italic>\u202f=\u202f14,515) from 2017 to 2022 to examine the age-specific pathogenesis and clinical manifestations of ETEC infections.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total ETEC was identified in 1,371 (9.4%) of surveillance samples. ETEC-associated diarrhea was higher in children aged 0\u20132\u202fyears and decreased significantly in the 3\u201317\u202fyears age group. Among all ETEC cases, 56% were adults (<jats:italic>p<\/jats:italic>\u202f=\u202f0.0079) with severe dehydration. Distinct age-specific distribution of ETEC toxin types and colonization factors (CFs) were observed: heat labile toxin (LT)-associated ETEC infections decreased with age (<jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.0001), while heat stable toxin (ST)-associated-ETEC was prevalent across all ages. Adults exhibited significantly higher rates of ETEC diarrhea with strains secreting both types of toxins. A high prevalence of antimicrobial resistance among ETEC strains, particularly in pediatric cases, with significant resistance observed against commonly used antibiotics such as azithromycin and in line with similar age specific toxin profiles. The most common CFs were CFA\/I, CS3, CS5, CS6, and CS21. CFA\/I positive ETEC infection was more common in children (<jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.001), while CS5 and CS6 were more common in adults (<jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.0001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The findings provide valuable insights into ETEC epidemiology, pathogenesis, and clinical manifestations. These observations imply that age-related differences in host-pathogen interactions exist for ETEC infections and this may influence the development of targeted vaccines or therapeutics and use in specific populations.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2024.1484162","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T06:25:56Z","timestamp":1733984756000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Age-dependent pathogenic profiles of enterotoxigenic Escherichia coli diarrhea in Bangladesh"],"prefix":"10.3389","volume":"12","author":[{"given":"Marjahan","family":"Akhtar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin Ara","family":"Begum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadia","family":"Isfat Ara Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mokibul Hassan","family":"Afrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrin","family":"Parvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afroza","family":"Akter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imam","family":"Tauheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ashraful","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward T.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraful Islam","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahima","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taufiqur Rahman","family":"Bhuiyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firdausi","family":"Qadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/s1473-3099(18)30475-4","article-title":"Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the global burden of disease study 1990-2016","volume":"18","author":"Khalil","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1128\/CMR.18.3.465-483.2005","article-title":"Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention","volume":"18","author":"Qadri","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e255","DOI":"10.1016\/s2214-109x(18)30045-7","article-title":"Global disability-adjusted life-year estimates of long-term health burden and undernutrition attributable to diarrhoeal diseases in children younger than 5 years","volume":"6","author":"Troeger","year":"2018","journal-title":"Lancet Glob Health"},{"key":"ref4","first-page":"322","article-title":"The returned traveller with diarrhoea","volume":"36","author":"Goldsmid","year":"2007","journal-title":"Aust Fam Physician"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.micpath.2018.02.032","article-title":"Review on pathogenicity mechanism of enterotoxigenic Escherichia coli and vaccines against it","volume":"117","author":"Mirhoseini","year":"2018","journal-title":"Microb Pathog"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1128\/CMR.11.1.142","article-title":"Diarrheagenic Escherichia coli","volume":"11","author":"Nataro","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.coi.2005.06.007","article-title":"Virulence factors, pathogenesis and vaccine protection in cholera and ETEC diarrhea","volume":"17","author":"Sanchez","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.micinf.2009.10.002","article-title":"Molecular mechanisms of enterotoxigenic Escherichia coli infection","volume":"12","author":"Fleckenstein","year":"2010","journal-title":"Microbes Infect"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2055943","DOI":"10.1080\/19490976.2022.2055943","article-title":"Enterotoxigenic Escherichia coli: intestinal pathogenesis mechanisms and colonization resistance by gut microbiota","volume":"14","author":"Zhang","year":"2022","journal-title":"Gut Microbes"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"7077","DOI":"10.1016\/j.vaccine.2014.10.069","article-title":"Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled phase I study","volume":"32","author":"Lundgren","year":"2014","journal-title":"Vaccine"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"5645","DOI":"10.1016\/j.vaccine.2018.11.040","article-title":"Evaluation of the safety and immunogenicity of the oral inactivated multivalent enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi adults in a double-blind, randomized, placebo-controlled phase I trial using electrochemiluminescence and ELISA assays for immunogenicity analyses","volume":"37","author":"Akhtar","year":"2018","journal-title":"Vaccine"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S1473-3099(19)30571-7","article-title":"Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1\/2 trial","volume":"20","author":"Qadri","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"102372","DOI":"10.1016\/j.coi.2023.102372","article-title":"Developments in oral enterotoxigenic Escherichia coli vaccines","volume":"84","author":"Svennerholm","year":"2023","journal-title":"Curr Opin Immunol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3390\/vaccines11050939","article-title":"Use of an ETEC proteome microarray to evaluate cross-reactivity of ETVAX(\u00ae) vaccine-induced IgG antibodies in Zambian children","volume":"11","author":"Mubanga","year":"2023","journal-title":"Vaccines"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/microorganisms12010090","article-title":"A perspective on the strategy for advancing ETVAX(\u00ae), an anti-ETEC diarrheal disease vaccine, into a field efficacy trial in Gambian children: rationale, challenges, lessons learned, and future directions","volume":"12","author":"Hossain","year":"2023","journal-title":"Microorganisms"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1332319","DOI":"10.3389\/fpubh.2024.1332319","article-title":"Epidemiology of enterotoxigenic Escherichia coli and impact on the growth of children in the first two years of life in Lima, Peru","volume":"12","author":"Pajuelo","year":"2024","journal-title":"Front Public Health"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"3961","DOI":"10.1128\/IAI.00459-07","article-title":"Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in Bangladesh","volume":"75","author":"Qadri","year":"2007","journal-title":"Infect Immun"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e3031","DOI":"10.1371\/journal.pntd.0003031","article-title":"Shift in phenotypic characteristics of enterotoxigenic Escherichia coli (ETEC) isolated from diarrheal patients in Bangladesh","volume":"8","author":"Begum","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1132927","DOI":"10.3389\/fpubh.2023.1132927","article-title":"A snap-shot of a diarrheal epidemic in Dhaka due to enterotoxigenic Escherichia coli and Vibrio cholerae O1 in 2022","volume":"11","author":"Tauheed","year":"2023","journal-title":"Front Public Health"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1128\/jcm.33.5.1054-1059.1995","article-title":"Multiplex PCR assay and simple preparation method for stool specimens detect enterotoxigenic Escherichia coli DNA during course of infection","volume":"33","author":"Stacy-Phipps","year":"1995","journal-title":"J Clin Microbiol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1128\/iai.19.2.727-736.1978","article-title":"Detection and characterization of colonization factor of enterotoxigenic Escherichia coli isolated from adults with diarrhea","volume":"19","author":"Evans","year":"1978","journal-title":"Infect Immun"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e0157415","DOI":"10.1371\/journal.pone.0157415","article-title":"Resistance pattern and molecular characterization of Enterotoxigenic Escherichia coli (ETEC) strains isolated in Bangladesh","volume":"11","author":"Begum","year":"2016","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fimmu.2023.1220130","article-title":"T helper cell responses in adult diarrheal patients following natural infection with enterotoxigenic Escherichia coli are primarily of the Th17 type","volume":"14","author":"Akhtar","year":"2023","journal-title":"Front Immunol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"e2822","DOI":"10.1371\/journal.pntd.0002822","article-title":"Antigen-specific memory B-cell responses to enterotoxigenic Escherichia coli infection in Bangladeshi adults","volume":"8","author":"Alam","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"5896","DOI":"10.4049\/jimmunol.1003789","article-title":"Escherichia coli heat-labile enterotoxin promotes protective Th17 responses against infection by driving innate IL-1 and IL-23 production","volume":"186","author":"Brereton","year":"2011","journal-title":"J Immunol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1093\/infdis\/153.3.527","article-title":"Local and systemic antibody responses to naturally acquired enterotoxigenic Escherichia coli diarrhea in an endemic area","volume":"153","author":"Stoll","year":"1986","journal-title":"J Infect Dis"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1586\/erv.12.12","article-title":"Recent progress toward an enterotoxigenic Escherichia coli vaccine","volume":"11","author":"Svennerholm","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.tim.2023.11.001","article-title":"Colonization factors of human and animal-specific enterotoxigenic Escherichia coli (ETEC)","volume":"32","author":"von Mentzer","year":"2023","journal-title":"Trends Microbiol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1016\/j.vaccine.2005.08.110","article-title":"Reduced doses of oral killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine is safe and immunogenic in Bangladeshi infants 6-17 months of age: dosing studies in different age groups","volume":"24","author":"Qadri","year":"2006","journal-title":"Vaccine"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.vaccine.2012.12.063","article-title":"Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA\/I overexpressing bacteria and recombinantly produced LTB\/CTB hybrid protein","volume":"31","author":"Lundgren","year":"2013","journal-title":"Vaccine"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"6167","DOI":"10.1016\/j.vaccine.2011.06.084","article-title":"A systematic review of ETEC epidemiology focusing on colonization factor and toxin expression","volume":"29","author":"Isidean","year":"2011","journal-title":"Vaccine"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1128\/JCM.01639-13","article-title":"Pathogenicity and phenotypic characterization of enterotoxigenic Escherichia coli isolates from a birth cohort of children in rural Egypt","volume":"52","author":"Mansour","year":"2014","journal-title":"J Clin Microbiol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"4862","DOI":"10.1128\/JCM.41.10.4862-4864.2003","article-title":"High disease burden of diarrhea due to enterotoxigenic Escherichia coli among rural Egyptian infants and young children","volume":"41","author":"Rao","year":"2003","journal-title":"J Clin Microbiol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"6783","DOI":"10.1016\/j.vaccine.2017.07.036","article-title":"Global burden of diarrheal diseases among children in developing countries: incidence, etiology, and insights from new molecular diagnostic techniques","volume":"35","author":"Kotloff","year":"2017","journal-title":"Vaccine"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0140-6736(13)60844-2","article-title":"Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the global enteric multicenter study, GEMS): a prospective, case-control study","volume":"382","author":"Kotloff","year":"2013","journal-title":"Lancet"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"e0007037","DOI":"10.1371\/journal.pntd.0007037","article-title":"Colonization factors among enterotoxigenic Escherichia coli isolates from children with moderate-to-severe diarrhea and from matched controls in the global enteric multicenter study (GEMS)","volume":"13","author":"Vidal","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"957","DOI":"10.3389\/fimmu.2017.00957","article-title":"Postnatal innate immune development: from birth to adulthood","volume":"8","author":"Georgountzou","year":"2017","journal-title":"Front Immunol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1099\/mic.0.065532-0","article-title":"Enterotoxigenic Escherichia coli CS21 pilus contributes to adhesion to intestinal cells and to pathogenesis under in vivo conditions","volume":"159","author":"Guevara","year":"2013","journal-title":"Microbiology"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3389\/fmicb.2014.00709","article-title":"CS21 positive multidrug-resistant ETEC clinical isolates from children with diarrhea are associated with self-aggregation, and adherence","volume":"5","author":"Cruz-C\u00f3rdova","year":"2014","journal-title":"Front Microbiol"},{"key":"ref40","first-page":"1978","article-title":"DmLT adjuvanted live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine candidate protects against virulent ETEC in a human ETEC challenge model","volume-title":"Vaccines against enteric disease","author":"Harro","year":"2019"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fitd.2021.709907","article-title":"Confronting challenges to enterotoxigenic Escherichia coli vaccine development","volume":"2","author":"Fleckenstein","year":"2021","journal-title":"Front Trop Dis"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"e0068323","DOI":"10.1128\/aem.00683-23","article-title":"Polyvalent protein adhesin MEFA-II induces functional antibodies against Enterotoxigenic Escherichia coli (ETEC) adhesins CS7, CS12, CS14, CS17, and CS21 and heat-stable toxin (STa)","volume":"89","author":"Upadhyay","year":"2023","journal-title":"Appl Environ Microbiol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1586\/14760584.2014.905745","article-title":"Novel antigens for enterotoxigenic Escherichia coli vaccines","volume":"13","author":"Fleckenstein","year":"2014","journal-title":"Expert Rev Vaccines"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2024.1484162\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T06:25:59Z","timestamp":1733984759000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2024.1484162\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,12]]},"references-count":43,"alternative-id":["10.3389\/fpubh.2024.1484162"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2024.1484162","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,12]]},"article-number":"1484162"}}